Applied UV, Inc. · OTC:AUVI

Applied UV — Investor Presentation (December 2023)

27 slides from Applied UV's investor presentation, December 2023

  1. Slide 1: Investor Presentation

    March 2023 Nasdaq: AUVI, AUVIP B e t t e r A i r . B e t t e r L i g h t . B e t t e r B u s i n e s s . B e t t e r L i f e . ™️ Investor Presentation Global Leader in Integrated Innovations for Air and Surface Pathogen Elimination, LED Lighting and Hospitality Furnishings December 2023 Our Brands

  2. Slide 2: Safe Harbor Statement

    Safe Harbor Statement Nasdaq: AUVI, AUVIP This presentation may contain “forward-looking statements.” Forward-looking statements reflect the current view about future events. When used in this prospectus, the words “anticipate,” “believe,” “estimate,” “expect,” “future,” “intend,” “plan,” or the neg

  3. Slide 3: Investor Highlights

    Investor Highlights Nasdaq: AUVI, AUVIP AUVI is a fully integrated engineering, sales, and marketing company offering proprietary, patented air and surface (fixed, consumer, HVAC and mobile) pathogen elimination products, LED lighting and luxury mirrors and premium hospitality furnishings to global

  4. Slide 4: Key Investor Takeaways

    Investor Key Highlights Takeaways Nasdaq: AUVI, AUVIP MARKET: UV Disinfection market is expected to reach $9 billion by 2026 - CDC estimates that 01 GROWING MARKET 1 in 25 patients have at least one HAI annually & 3M serious infections occur every year with total losses to U.S. economy of more than

  5. Slide 5: UV Disinfection Market: Compelling Growth Drivers

    UV Disinfection Market: Compelling Growth Drivers Nasdaq: AUVI, AUVIP Global air purifier market size is set to grow exponentially. Valued at $9.24 billion in 2021 and predicted to reach $22.84 billion by 2030; UV Disinfection market expected to reach $9 billion by 2026 as technology adapts and evol

  6. Slide 6: Deeper Dive - Product Overview

    Deeper Dive - Product Overview Nasdaq: AUVI, AUVIP Lab validated, data driven pathogen elimination solutions for air and surface applications Air Purification Surface Disinfection Independently tested for and eliminates COVID-19 Independently tested for and eliminates OC-43, a surrogate for SARS Cov

  7. Slide 7: Air Disinfection

    Air Disinfection Nasdaq: AUVI, AUVIP o Co-Developed for use by NASA to provide safe, clean air o Destroys 99.99% of airborne bacteria, mold, fungi and viruses o Advanced bioconversion technology uses photocatalytic oxidation to fully destroy airborne bacteria, mold, fungi, viruses, volatile organic

  8. Slide 8: Airocide is Scientific Superiority

    Airocide is Scientific Superiority From the farm to the fork, developed for NASA, Airocide is beneficial for the perishable industry With Airocide Without Airocide CONTROLS DESTROYS STOPS HAZARDOUS EXTENDS SHELF ETHYLENE GAS AIRBORNE MOLD CROSS- LIFE & BACTERIA CONTAMINATION REDUCES SHRINK SLOWS ENA

  9. Slide 9: Facility Level Disinfection Solutions

    HVAC Air Disinfection Nasdaq: AUVI, AUVIP Facility Level Disinfection Solutions o Innovative HVAC air and coil disinfection solutions o Continuous in-room air disinfection technologies o Hospital-grade surface disinfection solutions o Patented air and surface technologies © Copyright 2022 Applied UV

  10. Slide 10: PURONet UV IAQ Disinfection Control System

    IAQ Monitoring Software Nasdaq: AUVI, AUVIP PURONet UV IAQ Disinfection Control System UV Safety, Control and Reporting All In One Place o First control system of its kind specifically designed for user-friendly operation o Controls PURO Fixtures within a room providing safe operation and data colle

  11. Slide 11: Mobile Air Disinfection

    Mobile Air Disinfection Nasdaq: AUVI, AUVIP o Laboratory validated 99.99%+ kill rate on viruses, bacteria, mold, odors and VOCS o NO harmful by-products o Rapid, portable, whole-room disinfection via patented 3-phase design (HEPA, UV-C, Carbon) o Proven and tested in facilities with EPA and FDA guid

  12. Slide 12: Surface Disinfection

    Surface Disinfection Nasdaq: AUVI, AUVIP Backed by Biosafety Level II and III labs, is proven to kill 99.99%+ of pathogens on surfaces including: • SARS-CoV-2 surrogate (OC-43), MRSA, H1N1, Candida Auris (C. auris), C. diff and E. coli • June 2022 Mt Sinai Medical Center Morningside Installed – test

  13. Slide 13: Strong Business Case Use Across Multiple Verticals

    Strong Business Case Use Across Multiple Verticals IAQ Product Suite From Small Applications to Commercial / Heavy Industrial Agriculture Transportation Healthcare Food and Beverage Post-harvest Food Distribution and Logistics Hospitals Winery, Dairy, Meat & Preservations and Cannabis from “Farm To

  14. Slide 14: Competitive Advantages

    Competitive Advantages Nasdaq: AUVI, AUVIP AUVI is one of the only research-backed, clinically-proven air and surface disinfection technology companies with international distribution and globally recognized end users with product co-developed for use by NASA Few Dominant Players Global Push Highly

  15. Slide 15: Differentiator - Global Distribution Footprint

    Differentiator - Global Distribution Footprint Nasdaq: AUVI, AUVIP Scandinavia Europe • One Major Distributor (Dental) • One Master Distributor • 20 Retailers Asia • Nine Dealer Distributors United States • 24 Dealers/Distributors • 5-10 New Direct Sales Vietnam • Nine Dealer Distributors South Amer

  16. Slide 16: Backed By Compelling Research

    Backed By Compelling Research Nasdaq: AUVI, AUVIP MRIGlobal, an independent, not-profit, Kansas City, Missouri Georgia State University Study – PURO™ Helo Effectiveness • Demonstrated effective removal of aerosolized SARS-CoV-2 ▪ Demonstrated effective removal of aerosolized SARS- virus from surface

  17. Slide 17: Hospitality Segment

    E X T R A O R D I N A R Y M I R R O R S A N D F U R N I S H I N G S A global manufacturer of luxury and backlit mirrors, patented - disinfection mirrors utilizing the SteriLumen proprietary PCO technology and premium conference room and living space furnishings, specifically for the hospitality indu

  18. Slide 18: MUNNWORKS

    MUNNWORKS Nasdaq: AUVI, AUVIP MUNNWORKS OUR PROMISE: DESIGNS TO YOUR SPECS, WITHIN BUDGET AND DELIVERED ON-TIME. 100+ EMPLOYEES DOMESTIC MANUFACTURING FACILITIES: MT VERNON, NY – 50,000 SQ FT FACTORY BROOKLYN, NY – 100,000 SQ FT FACTORY PRODUCTS & SERVICES: LIGHTED MIRRORS HOSPITALITY MIRRORS CONTRA

  19. Slide 19: Single Source Lighting, Controls and Technology Provider

    LED LIGHTING AND CONTROLS Nasdaq: AUVI, AUVIP Single Source Lighting, Controls and Technology Provider By offering more products and technologies, we help streamline decisions, save time and resources at the corporate level down through construction for new construction and renovation projects: o LE

  20. Slide 20: Organic Growth - Marketing

    Organic Growth - Marketing Nasdaq: AUVI, AUVIP Effective and efficient marketing that increases customer count and revenue and wins the hearts and minds of target audience Targeted Product by Integrated Marketing Performance Metrics Vertical Programs • Increase quality sales leads Airocide • Digital

  21. Slide 21: Consolidated Statement of Operations

    Consolidated Statement of Operations Nasdaq: AUVI, AUVIP Applied UV, Inc. and Subsidiaries Unaudited Condensed Interim Consolidated Statements of Operations For the Three and Nine Months Ended September 30, 2023 and 2022 Net Sales by Segment For the Three Months Ended September 30, For the Nine Mont

  22. Slide 22: Cap Table

    Cap Table Nasdaq: AUVI, AUVIP Preferred Stock Par Authorized / Outstanding Designated (as of December 4, 2023) Total Authorized $0.0001 20,000,000 Series A Cumulative Perpetual $0.0001 1,250,000 552,000 Series B Cumulative Perpetual $0.0001 1,250,000 1,250,000 Series C Cumulative Perpetual $0.0001 2

  23. Slide 23: Experienced Leadership Team

    Experienced Leadership Team Nasdaq: AUVI, AUVIP Max Munn Michael Riccio Brian Stern Andrew Lawrence Founder, CEO, President CFO President PURO UV President LED Supply CO and Director and Director • Mr. Munn has held this position at • Former CFO and Treasurer of • Co-Founder of both PURO • Co-Founde

  24. Slide 24: Experienced, Independent Board

    Experienced, Independent Board Nasdaq: AUVI, AUVIP • President/CEO GranCare Inc, acquired by Apollo and merged with Living Centers of America to form Mariner • Chairman Mariner Post-Acute Network • President/COO and Director American Medical International (AMI) • Chairman Alterra Healthcare • Invest

  25. Slide 25: Scientific Advisory Board

    Scientific Advisory Board Nasdaq: AUVI, AUVIP • Professor of Medicine at the Icahn School of Medicine at Mount Sinai and the Infection Prevention Medical Director for the eight-hospital Mount Sinai Health System in NY • Dr. Cumins received his medical degree from Emory University School of Medicine

  26. Slide 26: Looking Ahead: 2023 and Beyond

    1 2 3 Target Key Verticals Prioritize Organic Growth Scalability Moving from opportunistic to Leverage cross selling opportunities• Fully optimize Canon focused approach with proven key among brands driven by: Virginia contract Looking Ahead: verticals • Govt mandates for healthcare manufacturing in

  27. Slide 27: Applied UV, Inc.

    Contact: Nasdaq: AUVI, AUVIP Applied UV, Inc. Max Munn Founder, CEO, President and Director 150 N. Macquesten Parkway Mount Vernon, NY 10550 914-391-6464 Better Air. Better Light. Better Business. Better Life. ™️

Applied UV — Investor Presentation (December 2023) on 6ix